发明名称 HUMANIZATION AND AFFINITY-OPTIMIZATION OF ANTIBODIES
摘要 <p>In an efficient selection of higher affinity binders for an antibody humanization strategy, original CDRs are grafted, but no homology modeling is required to determine the key residues in a framework region. One human variable region heavy chain or "VH' and one variable region light chain or 'VL" germline segments show characteristics of high expression in E. coli as a universal template. Key residues in the framework scaffold were determined by screening of available antibody crystal structure data as well as published documents that described the refinements of a specific mouse humanization project. Diversified residues that represent either human antibody selections or mouse selections were integrated into those key framework positions that were assumed to be important in either supporting CDRs or affecting the overall domain structure. A phage display Fab library was used to screen functional reshaped antibodies, which facilitates the isolation of well-maintained clones in a standard panning.</p>
申请公布号 WO2010056893(A1) 申请公布日期 2010.05.20
申请号 WO2009US64247 申请日期 2009.11.12
申请人 IMCLONE LLC;HAIDAR, JAAFAR, NASSAR SLEIMAN;YUAN, QING-AN;ZHU, ZHENPING 发明人 HAIDAR, JAAFAR, NASSAR SLEIMAN;YUAN, QING-AN;ZHU, ZHENPING
分类号 C07K16/46;C12P21/08;G01N33/48 主分类号 C07K16/46
代理机构 代理人
主权项
地址